Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine.

[1]  C. Coban,et al.  Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets. , 2014, Vaccine.

[2]  S. Reed,et al.  Key roles of adjuvants in modern vaccines , 2013, Nature Medicine.

[3]  M. Kiso,et al.  A Novel Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice from Pandemic H1N1 and Highly Pathogenic H5N1 Virus Challenges , 2013, Journal of Virology.

[4]  K. Ishii,et al.  Adjuvants in influenza vaccines. , 2012, Vaccine.

[5]  Y. Kawaoka,et al.  Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. , 2012, Vaccine.

[6]  Tadaki Suzuki,et al.  Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. , 2012, Vaccine.

[7]  M. Tashiro,et al.  Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine , 2012, Journal of medical virology.

[8]  Ryo Takano,et al.  Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice. , 2011, Virus research.

[9]  G. Neumann,et al.  The first influenza pandemic of the new millennium , 2011, Influenza and other respiratory viruses.

[10]  I. Srivastava,et al.  Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens , 2011, Expert review of vaccines.

[11]  A. Fauci,et al.  Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine , 2010, Nature Medicine.

[12]  M. Olivier,et al.  Innate inflammatory response to the malarial pigment hemozoin. , 2010, Microbes and infection.

[13]  Jin Hyun Kim,et al.  Biological and Structural Characterization of a Host-Adapting Amino Acid in Influenza Virus , 2010, PLoS pathogens.

[14]  Sanjeev Kumar,et al.  Protein–DNA Complex Is the Exclusive Malaria Parasite Component That Activates Dendritic Cells and Triggers Innate Immune Responses , 2010, The Journal of Immunology.

[15]  C. Coban,et al.  Immunogenicity of Whole-parasite Vaccines against Plasmodium Falciparum Involves Malarial Hemozoin and Host Tlr9 , 2022 .

[16]  I. Stephenson,et al.  Influenza vaccines for the future , 2009 .

[17]  W. Cao,et al.  Increased sensitivity for detecting avian influenza-specific antibodies by a modified hemagglutination inhibition assay using horse erythrocytes. , 2008, Journal of virological methods.

[18]  G. Kayali,et al.  Testing human sera for antibodies against avian influenza viruses: horse RBC hemagglutination inhibition vs. microneutralization assays. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[19]  A. Osterhaus,et al.  Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. , 2007, Current opinion in biotechnology.

[20]  B. Monks,et al.  Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9 , 2007, Proceedings of the National Academy of Sciences.

[21]  C. Coban,et al.  Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin , 2005, The Journal of experimental medicine.

[22]  N. Petrovsky,et al.  Vaccine adjuvants: Current state and future trends , 2004, Immunology and cell biology.

[23]  W. Glezen.  Cold-adapted, live attenuated influenza vaccine , 2004, Expert review of vaccines.

[24]  R. Cox,et al.  Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines , 2004, Scandinavian journal of immunology.

[25]  J. A. Misplon,et al.  Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or γδ T Cells1 , 2001, The Journal of Immunology.

[26]  T. Tumpey,et al.  Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection , 2001, Journal of Virology.

[27]  J. A. Misplon,et al.  Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells. , 2001, Journal of immunology.

[28]  P. Arese,et al.  Malarial pigment (haemozoin): a very active 'inert' substance. , 1997, Annals of tropical medicine and parasitology.

[29]  D. Sullivan,et al.  Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. , 1997, Annual review of microbiology.

[30]  R. Jonsson,et al.  Parenteral influenza vaccination induces a rapid systemic and local immune response. , 1995, The Journal of infectious diseases.

[31]  J. Oxford,et al.  An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. , 1994, Vaccine.

[32]  B. Murphy,et al.  Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus , 1986, Journal of clinical microbiology.

[33]  R. Webster,et al.  Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. , 1982, Virology.